Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Gut Dysbiosis and Adaptive Immune Response in Diet-induced Obesity vs. Systemic Inflammation

J. Pindjakova, C. Sartini, O. Lo Re, F. Rappa, B. Coupe, B. Lelouvier, V. Pazienza, M. Vinciguerra,

. 2017 ; 8 (-) : 1157. [pub] 20170622

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17032064

A mutual interplay exists between adaptive immune system and gut microbiota. Altered gut microbial ecosystems are associated with the metabolic syndrome, occurring in most obese individuals. However, it is unknown why 10-25% of obese individuals are metabolically healthy, while normal weight individuals can develop inflammation and atherosclerosis. We modeled these specific metabolic conditions in mice fed with a chow diet, an obesogenic but not inflammatory diet-mimicking healthy obesity, or Paigen diet-mimicking inflammation in the lean subjects. We analyzed a range of markers and cytokines in the aorta, heart, abdominal fat, liver and spleen, and metagenomics analyses were performed on stool samples. T lymphocytes infiltration was found in the aorta and in the liver upon both diets, however a significant increase in CD4+ and CD8+ cells was found only in the heart of Paigen-fed animals, paralleled by increased expression of IL-1, IL-4, IL-6, IL-17, and IFN-γ. Bacteroidia, Deltaproteobacteria, and Verrucomicrobia dominated in mice fed Paigen diet, while Gammaproteobacteria, Delataproteobacteria, and Erysipelotrichia were more abundant in obese mice. Mice reproducing human metabolic exceptions displayed gut microbiota phylogenetically distinct from normal diet-fed mice, and correlated with specific adaptive immune responses. Diet composition thus has a pervasive role in co-regulating adaptive immunity and the diversity of microbiota.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17032064
003      
CZ-PrNML
005      
20210309094511.0
007      
ta
008      
171025s2017 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fmicb.2017.01157 $2 doi
035    __
$a (PubMed)28690599
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Pindjakova, Jana $u Center for Translational Medicine, International Clinical Research Center, St. Anne's University HospitalBrno, Czechia.
245    10
$a Gut Dysbiosis and Adaptive Immune Response in Diet-induced Obesity vs. Systemic Inflammation / $c J. Pindjakova, C. Sartini, O. Lo Re, F. Rappa, B. Coupe, B. Lelouvier, V. Pazienza, M. Vinciguerra,
520    9_
$a A mutual interplay exists between adaptive immune system and gut microbiota. Altered gut microbial ecosystems are associated with the metabolic syndrome, occurring in most obese individuals. However, it is unknown why 10-25% of obese individuals are metabolically healthy, while normal weight individuals can develop inflammation and atherosclerosis. We modeled these specific metabolic conditions in mice fed with a chow diet, an obesogenic but not inflammatory diet-mimicking healthy obesity, or Paigen diet-mimicking inflammation in the lean subjects. We analyzed a range of markers and cytokines in the aorta, heart, abdominal fat, liver and spleen, and metagenomics analyses were performed on stool samples. T lymphocytes infiltration was found in the aorta and in the liver upon both diets, however a significant increase in CD4+ and CD8+ cells was found only in the heart of Paigen-fed animals, paralleled by increased expression of IL-1, IL-4, IL-6, IL-17, and IFN-γ. Bacteroidia, Deltaproteobacteria, and Verrucomicrobia dominated in mice fed Paigen diet, while Gammaproteobacteria, Delataproteobacteria, and Erysipelotrichia were more abundant in obese mice. Mice reproducing human metabolic exceptions displayed gut microbiota phylogenetically distinct from normal diet-fed mice, and correlated with specific adaptive immune responses. Diet composition thus has a pervasive role in co-regulating adaptive immunity and the diversity of microbiota.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sartini, Claudio $u Department of Primary Care and Population Health, University College LondonLondon, United Kingdom.
700    1_
$a Lo Re, Oriana $u Center for Translational Medicine, International Clinical Research Center, St. Anne's University HospitalBrno, Czechia.
700    1_
$a Rappa, Francesca $u Section of Human Anatomy, Department of Experimental Biomedicine and Clinical Neurosciences, University of PalermoPalermo, Italy.
700    1_
$a Coupe, Berengere $u VaiomerLabège, France.
700    1_
$a Lelouvier, Benjamin $u VaiomerLabège, France.
700    1_
$a Pazienza, Valerio $u Gastroenterology Unit, IRCCS "Casa Sollievo della Sofferenza" HospitalSan Giovanni Rotondo, Italy.
700    1_
$a Vinciguerra, Manlio $u Center for Translational Medicine, International Clinical Research Center, St. Anne's University HospitalBrno, Czechia. Division of Medicine, Institute for Liver and Digestive Health, University College LondonLondon, United Kingdom.
773    0_
$w MED00181714 $t Frontiers in microbiology $x 1664-302X $g Roč. 8, č. - (2017), s. 1157
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28690599 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20210309094506 $b ABA008
999    __
$a ind $b bmc $g 1255657 $s 993091
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 8 $c - $d 1157 $e 20170622 $i 1664-302X $m Frontiers in microbiology $n Front Microbiol $x MED00181714
LZP    __
$a Pubmed-20171025

Najít záznam

Citační ukazatele

Možnosti archivace